Research

Hormonal

Inhibition of liver-specific miR-122 using the antagomiR Miravirsen suppresses Hepatitis C Virus (HCV) replication.

Miravirsen is an antagomiR that targets miR-122 to treat Hepatitis C. This is a specialized medical treatment for a viral infection, distinct from general metabolic health advice.

ModerateSupportsMEDIUM confidence
MiR-122 is required for hepatitis C virus (HCV) replication (Jopling et al. 2005, 2008, Henke et al. 2008), and Miravirsen administration is able to suppress miR-122 expression and prevent HCV replication (Krutzfeldt et al. 2005, Ottosen et al. 2015).
Sara G. Vienberg et al. · Acta Physiologica · 2016

Why this rating

Review paper citing multiple studies; Miravirsen is a known therapeutic candidate.

Source

Micro<scp>RNA</scp>s in metabolism

Sara G. Vienberg et al. · Acta Physiologica · 2016

DOI 10.1111/apha.12681

narrative_reviewCited 371×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →